Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY26 results · Jan–Mar 2026
Amrutanjan Health Care reported revenue from operations of ₹149.77 crore (up 10.6% from Q4 FY25) and net profit of ₹16.19 crore (up 6.7% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a standalone basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 149.77 | 135.41 | +10.6% | 141.04 | +6.2% |
| Other income | 4.73 | 4.82 | −1.8% | 4.12 | +14.8% |
| Total income | 154.50 | 140.23 | +10.2% | 145.16 | +6.4% |
| Profit before tax | 21.02 | 20.86 | +0.8% | 26.36 | −20.3% |
| Net profit for the period | 16.19 | 15.18 | +6.7% | 19.45 | −16.8% |
| EPS, basic (₹) | 5.60 | 5.25 | +6.7% | 6.73 | −16.8% |
| Net margin (%) | 10.8 | 11.2 | 13.8 |
Standalone
- Filed with BSE
- 08 May 2026, 20:10 IST
- Board meeting
- 08 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE